Dutch automaker Spyker has been through the wringer for much of the past decade, with bankruptcy and financial woes that ...

Aileron Therapeutics’ unraveling has entered its endgame. An early look at phase 1b data persuaded the biotech to call it quits on development of its sole drug candidate—and lay off most of its ...

Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. Now, the biotech has distanced itself from its premerger form by rebranding ...

Lam Aviation advertised substantial performance gains (speed, fuel, climb, useful load) on a test aircraft, initially implying these improvements stemmed from their novel Lam aileron. The Lam aileron ...

Shares of Aileron Therapeutics, Inc. (ALRN) have been struggling lately and have lost 21% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean ...

Concept cars are exciting, but as often as not, they're also huge letdowns. Why? Because you know they'll be so neutered by the time they make production that it's the same car only in name (Jaguar XF ...

Spyker Cars may not have impressed in its F1 venture, but it certainly has made up for it off the track. The exclusive sportscar-maker has kept true to its promise made in March at the Geneva Auto ...

The word "focus" is written on one of Aileron's water features. Courtesy of Aileron To continue reading this content, please enable JavaScript in your browser ...

Whatever its credentials as a sports car—and they seem to be impressive—the Spyker C8 Aileron is an attention-getting device of pretty intense wattage. It even draws stares from the pilots of Ferraris ...